Free Trial

Zacks Research Analysts Boost Earnings Estimates for PAHC

Phibro Animal Health logo with Medical background

Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for Phibro Animal Health in a report issued on Wednesday, January 15th. Zacks Research analyst R. Department now forecasts that the company will earn $0.36 per share for the quarter, up from their previous forecast of $0.35. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2025 earnings at $0.43 EPS, FY2025 earnings at $1.49 EPS, Q2 2026 earnings at $0.50 EPS, Q4 2026 earnings at $0.51 EPS, FY2026 earnings at $1.67 EPS and Q2 2027 earnings at $0.54 EPS.

A number of other equities research analysts also recently weighed in on PAHC. StockNews.com downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Sunday, January 12th. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Finally, Barclays increased their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research note on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, Phibro Animal Health has a consensus rating of "Hold" and an average price target of $20.50.

Read Our Latest Report on PAHC

Phibro Animal Health Trading Down 0.5 %

Phibro Animal Health stock traded down $0.11 during trading hours on Friday, reaching $20.82. 74,318 shares of the company's stock traded hands, compared to its average volume of 138,811. The firm has a market capitalization of $843.21 million, a price-to-earnings ratio of 48.42, a PEG ratio of 0.52 and a beta of 0.53. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. Phibro Animal Health has a fifty-two week low of $10.03 and a fifty-two week high of $25.98. The firm's 50 day moving average is $22.50 and its 200-day moving average is $21.20.

Institutional Investors Weigh In On Phibro Animal Health

Several large investors have recently bought and sold shares of PAHC. nVerses Capital LLC bought a new position in shares of Phibro Animal Health during the third quarter worth $70,000. Quantbot Technologies LP acquired a new stake in Phibro Animal Health during the 3rd quarter worth $70,000. China Universal Asset Management Co. Ltd. lifted its holdings in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after acquiring an additional 1,522 shares in the last quarter. CWM LLC grew its stake in Phibro Animal Health by 190.8% in the third quarter. CWM LLC now owns 6,363 shares of the company's stock valued at $143,000 after acquiring an additional 4,175 shares during the period. Finally, Algert Global LLC bought a new stake in shares of Phibro Animal Health in the second quarter worth about $193,000. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.31%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health's payout ratio is 111.63%.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

See Also

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Should You Invest $1,000 in Phibro Animal Health Right Now?

Before you consider Phibro Animal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.

While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines